In 2016 both Cytiva and the Swedish Ministry of Enterprise and Innovation where reviewing options for accelerating growth for innovative technologies in Bio-pharma. Both parties agreed in 2016 to strike a deal to lower the thresholds into the bio-production by making modern Bio-pharma infrastructure available to the world in a way that benefits academia, small and medium companies developing, testing and verifying bio-production products and technology.